Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Other Non-Current Assets: 2018-2025

Historic Other Non-Current Assets for Neurogene (NGNE) over the last 6 years, with Sep 2025 value amounting to $1.1 million.

  • Neurogene's Other Non-Current Assets rose 34.73% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 34.73%. This contributed to the annual value of $975,000 for FY2024, which is 27.62% up from last year.
  • Latest data reveals that Neurogene reported Other Non-Current Assets of $1.1 million as of Q3 2025, which was down 3.01% from $1.1 million recorded in Q2 2025.
  • Neurogene's Other Non-Current Assets' 5-year high stood at $1.1 million during Q2 2025, with a 5-year trough of $524,000 in Q3 2023.
  • Moreover, its 3-year median value for Other Non-Current Assets was $794,000 (2024), whereas its average is $825,273.
  • Over the last 5 years, Neurogene's Other Non-Current Assets had its largest YoY gain of 50.57% in 2024, and its largest YoY loss of 17.90% in 2024.
  • Neurogene's Other Non-Current Assets (Quarterly) stood at $764,000 in 2023, then climbed by 27.62% to $975,000 in 2024, then surged by 34.73% to $1.1 million in 2025.
  • Its Other Non-Current Assets stands at $1.1 million for Q3 2025, versus $1.1 million for Q2 2025 and $896,000 for Q1 2025.